Wednesday, 16 October 2019

Drug Discovery News

  • Australia strengthens scientific collaboration with Indonesia

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Australian Academy of Science and the Indonesian Academy of Sciences have signed a new memorandum of understanding (MOU) on Scientific Cooperation. President of Australian Academ...Read more

  • China, Taiwan firms join hands for cancer drugs

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2013

    Singapore: Taiwan's PharmaEngine has signed research collaboration with Guangzhou BeBetter Medicine Technology to design, synthesize and develop new chemical entities against predefined tar...Read more

  • Amgen terminates AstraZeneca psoriasis drug partnership

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 27 May, 2015

    Singapore: Amgen has terminated the partnership with AstraZeneca for co-development and commercialization of brodalumab, an investigational IL-17 inhibitor for patients with moderate-to-sev...Read more

  • UCLA finds new compound to curb Alzheimer's

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

    Singapore: Researchers at University of California, Los Angeles (UCLA), US, have reported the development of a molecular compound, CLR01, which has been found to prevent toxic proteins from...Read more

  • Dainippon, Nippon Shinyaku sign deal for new drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: Dainippon Sumitomo Pharma (DSP), headquartered in Japan, and Nippon Shinyaku, also a Japanese company, have concluded a license agreement for exclusive rights to develop, manufac...Read more

  • AVEO, Astellas file NDA for tivozanib

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2012

    Singapore: US-based AVEO Oncology and Astellas Pharma have submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking approval for tivozanib in patients wit...Read more

  • Sanofi seeks approval for Lyxumia in Japan

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: Sanofi has submitted the marketing authorization application for Lyxumia, (lixisenatide), an investigational once-daily GLP-1 receptor agonist, to the Ministry of Health, Labour ...Read more

  • Cadila, Swedish firm develop arthritis drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jan, 2014

    Singapore: NovaSAID, part of Sweden-based Karolinska Development, and India- based Cadila Pharmaceuticals have entered into a strategic partnership to develop new treatments for inflammatio...Read more

  • Diabetes drug Actos doubles risk of bladder cancer

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2012

    Singapore: Canadian scientists have revealed that the diabetes drug pioglitazone, also known as Actos, doubles the risk of bladder cancer. However, the researchers found that in absolute te...Read more

  • Taiwan, China firms to co-develop cancer NCEs

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2013

    Singapore: Taiwan's PharmaEngine has collaborated and signed research agreement with China's Guangzhou BeBetter Medicine Technology. The two companies will collaborate to design, synthesize...Read more

  • Eisai to launch breast cancer drug in India

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

    Singapore: With an agenda to expand its footprint in the emerging markets, Japan's Eisai Pharma is launching its novel anti-cancer drug Eribulin, sold under the brand name of Halaven in Ind...Read more

  • Prana Biotech readies to progress PBT2 to market

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Australia-based Prana Biotechnology is to make senior appointments as it prepares to advance its key drug to treat Alzheimer's and Huntington diseases into late stage and pre-mar...Read more

  • Oramed recruits patients for oral insulin trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

    Singapore: Oramed Pharmaceuticals initiated patient recruitment for a new clinical trial of its orally ingestible insulin capsule,ORMD-0801, for patients with type 1 diabetes mellitus (T1DM...Read more

  • GlobalData: New Zealand focuses on generics

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Feb, 2013

    Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emphasising on generics, despite the disproportionate growth in elderly ...Read more

  • Allied to soon get CE mark approval from EU

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

    Singapore: Australia's Allied Healthcare is progressing in the regulatory process for obtaining European CE Mark approval for CardioCel, its lead regenerative tissue product for the repair ...Read more

  • Rockefeller University finds genetic link to autism

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

    Singapore: A collaborative research effort at Duke University Medical Center and Rockefeller University has pinpointed the precise genetic footprint that links fragile X syndrome and autism...Read more

  • GSK, Theravance COPD drug gets FDA nod

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Apr, 2013

    Singapore: The US FDA's Pulmonary-Allergy Drugs Advisory Committee (PADAC) has approved GlaxoSmithKline (GSK) and Theravance's Breo Ellipta as a once-daily inhaled treatment for the long-te...Read more

  • Bayer gets Japan's nod for gastro tumor drug

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

    Singapore: Bayer has received Japan's approval for Stivarga indicated for the treatment of patients suffering from gastrointestinal stromal tumor (GIST) who have progressed following prior ...Read more



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls